Search results for: 'peptides market GLP-1'
- Did you mean
- peptid market gdp 1
- peptide market gp 1
- Related search terms
- Markets and Markets
- market analysis of rf energy harvesting technolog
- market analysi of rf energy harvesting technolog
- market+size+of+china's+overseas+marketing+industry
- market 08 00 00 00
-
05 Oct 2026  |  Global  |  Market Research
Impact of GLP-1 on Nutraceuticals, Global, 2025–2032
The Nutraceuticals Industry is Experiencing Transformational Growth due to the Rapid Adoption of GLP-1 Therapies, Emerging Nutritional Gaps, and Increasing Demand for Targeted Nutrition Solutions
The rapid adoption of GLP-1 therapies is reshaping the weight management landscape and creating a new set of nutritional needs among consumers using these treatments. While GLP-1 therapies have demonstrated significant benefits for weight loss and metabolic health, associated challenges—including reduced appetite and food intake, loss of lean muscl...
$2,450.00 -
08 Sep 2025  |  Global  |  Market Research
Growth Opportunities in Global Protein and Peptide Therapeutics, Forecast to 2030
Cross-Therapeutic Expansion is Driving Transformational Growth Fueled by Novel Formats and Smarter Delivery
The protein and peptide therapeutics industry is undergoing a profound transformation, driven by next-generation biologics, including multi-specific antibodies, antibody-drug conjugates (ADCs), and GLP-1 treatments. These advances are intensifying competition, while the patent expiries of blockbuster antibodies are accelerating the entry of biosimi...
$4,950.00 -
23 Oct 2025  |  Global  |  Market Research
Navigating the Weight Management Ingredients Market in the Nutraceutical Industry
GLP-1-Supporting Ingredients Reshaping Weight Management and Driving Transformational Growth
Weight management is a growing area of interest in the nutraceutical industry, driven by rising obesity rates and increasing consumer demand for natural health solutions.Nutraceutical ingredients used in weight management include a diverse range of bioactive compounds that support fat metabolism, appetite regulation, thermogenesis, and glycemic con...
$2,450.00 -
30 Jul 2024  |  Global  |  Market Research
Chinese Tier 1 Automotive Suppliers Market, Global, 2024–2030
Connected, Autonomous, and Electric Vehicles are Driving Transformational Growth and Globalization of Suppliers by 2030
Like most industries in 2024, technological advances, shifting consumer preferences, and regulatory changes are transforming the global automotive industry. Frost & Sullivan’s analysis shows that Chinese Tier 1 suppliers have emerged as pivotal players in this dynamic environment, leveraging their technological capabilities and innovative prowess t...
$4,950.00
Special Price $4,207.50 save 15 %
-
14 Jun 2024  |  Global  |  Market Research
Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024 2028
GLP-1 RA Drug Class, Combination Therapies, and Digital Convergence for Affordable Disease Management Drive Growth
Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...
$4,950.00
Special Price $3,712.50 save 25 %
-
10 Jul 2026  |  Global  |  Technology Research
Growth Opportunities in Sub-1 Nm Chip technology, MMIC, SOC, Photonic Chiplet, GaN and Power Electronics
Microelectronics Technology Opportunity Engine
The Microelectronics Technology Opportunity Engine covers innovations pertaining to Sub-1 Nm Chip technology, MMIC, SOC, Photonic Chiplet, GaN and Power Electronics among others.The Microelectronics Technology Opportunity Engine captures global electronics-related innovations and developments on a weekly basis. Developments are centered on electron...
$950.00 -
28 Nov 2023  |  Global  |  Technology Research
Growth Opportunities in Obesity Drugs and Delivery Platforms
GLP-1-based Drugs, Along With Injector and Nanomaterial Delivery Platforms, Drive Transformational Industry Growth
The increasing disposable incomes in developing countries have contributed to a sedentary lifestyle worldwide. The advent of food delivery apps has also increased accessibility to various culinary delights. These factors have contributed mainly to obesity and other lifestyle diseases. People with a body mass index (BMI) of more than or equal to...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Sep 2010  |  Global  |  Technology Research
Advances in Peptide Therapeutics (Technical Insights)
Peptides have been prevalent as biopharmaceutical entities since the past twenty years but have come into focus only in the last five to six years due to improvements in manufacturing processes and delivery technologies. This research service aims to provide a strategic picture of therapeutic peptides from a research and development portfolio persp...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 May 2024  |  Global  |  Market Research
Diabetes Care Devices, Forecast to 2028
Growth Opportunities in AI and GLP-1 will Drive the Expansion of Type 2 Diabetes Devices
This study provides a detailed overview of the global diabetes care device industry, which is witnessing a significant increase in demand due to the growing prevalence of diabetes across regions. The market, comprising both established players and emerging start-ups, is the site of fierce competition. OEMs are developing innovative, AI-equipped tec...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Nov 2020  |  Global  |  Technology Research
Analysing Sepsis Management Part II: Treatments
Recent developments in Sepsis Treatment focused towards antibiotics, inhibitors, antibodies, peptides, recombinant proteins, antibacterial, antifungal, antivirals, vaccines, and probiotics
Sepsis is a life-threatening condition caused by overactivation of host immune system upon infections which may lead to organ failure and potentially death. World Health Organization designates sepsis as a global public health priority. Several studies conducted to understand the molecular basis of sepsis, septic shock, and organ failure. Despite e...
$4,950.00
Special Price $3,712.50 save 25 %